Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Fibroma 1Desmoid Tumors 1Advanced Solid Tumors 1

Interventions

nirogacestat 1navoximod 1ixabepilone 1atezolizumab 1Topotecan 1Radiosurgery 1Pemetrexed 1Lapatinib 1Hydroxyurea 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Advanced Solid Tumors × Hydroxyurea × Clear all
NCT01521299 2012-08-28

A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors

Dartmouth-Hitchcock Medical Center

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡